The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer

被引:23
|
作者
Castro, Elena [1 ,2 ]
Mikropoulos, Christos [1 ,2 ]
Bancroft, Elizabeth K. [1 ,2 ]
Dadaev, Tokhir [1 ]
Goh, Chee [1 ,2 ]
Taylor, Natalie [1 ,2 ]
Saunders, Edward [1 ]
Borley, Nigel [2 ]
Keating, Diana [1 ]
Page, Elizabeth C. [1 ]
Saya, Sibel [1 ]
Hazell, Stephen [3 ]
Livni, Naomi [3 ]
deSouza, Nandita [4 ]
Neal, David [5 ,6 ]
Hamdy, Freddie C. [7 ]
Kumar, Pardeep [2 ]
Antoniou, Antonis C. [8 ]
Kote-Jarai, Zsofia [1 ]
Eeles, Rosalind A. [1 ,2 ]
机构
[1] Inst Canc Res, Oncogenet Team, London SW3 6JB, England
[2] Royal Marsden Natl Hlth Serv Fdn Trust, Acad Urol Unit, London, England
[3] Royal Marsden Natl Hlth Serv Fdn Trust, Histopathol Dept, London, England
[4] Inst Canc Res, Div Radiotherapy & Imaging, Sutton SM2 5NG, Surrey, England
[5] Canc Res UK Cambridge Inst, Dept Oncol, Cambridge, England
[6] Canc Res UK Cambridge Inst, Dept Surg, Cambridge, England
[7] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England
[8] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England
来源
ONCOLOGIST | 2016年 / 21卷 / 06期
基金
加拿大健康研究院;
关键词
Prostate cancer; Family history; Single nucleotide polymorphisms; Prostate-specific antigen; GENETIC-VARIANTS; RISK; ANTIGEN; PREVALENCE; MARKERS; UTILITY; IMPACT;
D O I
10.1634/theoncologist.2015-0336
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has limitations and is not currently advocated. Approximately 100 common single nucleotide polymorphisms (SNPs) have been identified that are associated with the risk of developing PrCa. The PROFILE pilot study explored the feasibility of using SNP profiling in men with a family history (FH) of PrCa to investigate the probability of detecting PrCa at prostate biopsy (PB). The primary aim of this pilot study was to determine the safety and feasibility of PrCa screening using transrectal ultrasound-guided PB with or without diffusion-weighted magnetic resonance imaging (DW-MRI) in men with a FH. A secondary aim was to evaluate the potential use of SNP profiling as a screening tool in this population. Patients and Methods. A total of 100 men aged 40-69 years with a FH of PrCa underwent PB, regardless of their baseline PSA level. Polygenic risk scores (PRSs) were calculated for each participant using 71 common PrCa susceptibility alleles. We treated the disease outcome at PB as the outcome variable and evaluated its associations with the PRS, PSA level, and DW-MRI findings using univariate logistic regression. Results. Of the 100 men, 25 were diagnosed with PrCa, of whom 12 (48%) had clinically significant disease. Four adverse events occurred and no deaths. The PSA level and age at study entry were associated with PrCa at PB (p = .00037 and p = .00004, respectively). Conclusion. The results of the present pilot study have demonstrated that PB is a feasible and safe method of PrCa screening in men with a FH, with a high proportion of PrCa identified requiring radical treatment. It is feasible to collect data on PrCa-risk SNPs to evaluate their combined effect as a potential screening tool. A larger prospective study powered to detect statistical associations is in progress.
引用
收藏
页码:716 / 722
页数:7
相关论文
共 50 条
  • [21] Targeted screening for prostate cancer in African-American men
    JW Moul
    [J]. Prostate Cancer and Prostatic Diseases, 2000, 3 : 248 - 255
  • [22] PROSTATE CANCER RISK IN MEN WITH PROSTATE AND BREAST CANCER FAMILY HISTORY: RESULTS FROM THE REDUCE STUDY
    Thomas, Jean-Alfred
    Gerber, Leah
    Moreira, Daniel M.
    Hamilton, Robert J.
    Banez, Lionel L.
    Castro, Ramiro S.
    Andriole, Gerald L.
    Isaacs, William B.
    Xu, Jianfeng
    Freedland, Stephen J.
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E66 - E66
  • [23] Targeted screening for prostate cancer in African-American men
    Moul, JW
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 248 - 255
  • [24] Accuracy of family history of cancer as reported by men with prostate cancer
    King, TM
    Tong, L
    Pack, RJ
    Spencer, C
    Amos, CI
    [J]. UROLOGY, 2002, 59 (04) : 546 - 550
  • [25] Substantial Family History of Prostate Cancer in Black Men Recruited for Prostate Cancer Screening Results From the Prostate Cancer Risk Assessment Program
    Mastalski, Kathleen
    Coups, Elliot J.
    Ruth, Karen
    Raysor, Susan
    Giri, Veda N.
    [J]. CANCER, 2008, 113 (09) : 2559 - 2564
  • [26] The PROFILE study; Germline genetic profiling: Correlation with targeted prostate cancer screening and treatment
    Bancroft, Elizabeth Kathryn
    Castro, Elena
    Page, Elizabeth
    Saunders, Ed
    Dadaev, Tokhir
    Keating, Diana
    Amin, Ali
    Neai, David
    Hamdy, Freddie
    Easton, Doug
    Kote-Jarai, Zsofia
    Antoniou, Antonis
    Eeles, Rosalind
    [J]. CANCER RESEARCH, 2012, 72
  • [27] Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening
    Liss, Michael A.
    Chen, Haitao
    Hemal, Sij
    Krane, Spencer
    Kane, Christopher J.
    Xu, Jianfeng
    Kader, A. Karim
    [J]. JOURNAL OF UROLOGY, 2015, 193 (01): : 75 - 79
  • [28] IMPACT Study: Targeted Prostate Cancer Screening
    Mikropoulos, Christos
    Eeles, Rosalind A.
    [J]. ONCOLOGIST, 2013, 18 (08): : E28 - E28
  • [29] PSA screening: A comparison of attitudes and behaviour in US and UK men with a family history of prostate cancer
    McCurdy, Ron
    Moynahan, Clare
    Stewart, S.
    Bloom, Joan
    Watson, Maggie
    [J]. PSYCHO-ONCOLOGY, 2008, 17 : S249 - S249
  • [30] PSA Screening: A Comparison of Attitudes and Behaviour in US and UK Men with a Family History of Prostate Cancer
    McCurdy, R.
    Bloom, P.
    Moynihan C, S.
    Stewart, S.
    Watson, M.
    [J]. PSYCHO-ONCOLOGY, 2009, 18 (03) : 326 - 326